In this study, we aim to investigate whether quantitative parameters of synthetic MRI can be used to differentiate among molecular subtypes and prognostic factors in patients with breast cancer. It was concluded that SD of PD-Pre was significantly different between HER2-enriched and non-HER2-enriched breast cancers, which displayed optimal performance than others. Quantitative T2-Pre, T2-Gd, SD of PD-Pre, and SD of PD-Gd were significantly different in the molecular subtypes and can further differentiate luminal breast cancers from non-luminal subtypes. T1-Pre, T2-Pre, and SD of PD-Gd were significantly different between triple negative (TN) and non-TN breast cancers.
This abstract and the presentation materials are available to members only; a login is required.